TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012Vol.35 No.12
TCL Archive Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival December 28, 2012Vol.35 No.12
TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients December 28, 2012Vol.35 No.12
TCL Archive Scatter Radiation from Mammography Presents No Increased Cancer Risk December 28, 2012Vol.35 No.12
TCL Archive Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas December 28, 2012Vol.35 No.12
TCL Archive Margaret Kripke Comes Out of Retirement To Become Chief Scientific Officer at CPRIT December 14, 2012Vol.38 No.46
